Stephen E. Dippe

Design and Baseline Characteristics for the Aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II)

B. I. Freedman, Jean-Paul Wuerth, Kenneth Cartwright et al. · Controlled Clinical Trials · 1999 · 250 citations

Diabetes Management, Renal Function, Renal Disease +10

Characterization of the Glucagon Response to Hypoglycemia in Man

John E. Gerich, Victor Schneider, Stephen E. Dippe et al. · The Journal of Clinical Endocrinology & Metabolism · 1974 · 119 citations

Metabolic Syndrome, Physiological Research, Glucagon Response +15

Hyperinsulinemia and Hypoinsulinemia: Insulin Responses to Oral Carbohydrate Over a Wide Spectrum of Glucose Tolerance

Peter J. Savage, Stephen E. Dippe, Peter H. Bennett et al. · Diabetes · 1975 · 94 citations

Nutrition, Glucose Tolerance, Insulin Signaling +16

Postoperative wound infections detected during hsopitalization and after discharge in a community hospital

Sonia Burns, Stephen E. Dippe · American Journal of Infection Control · 1982 · 70 citations

Surgical Site Infections, Healthcare-associated Infection, Patient Safety +10

A Clinical and Histologic Study of Diabetic Nephropathy in the Pima Indians

Stephen A Kamenetzky, Peter H. Bennett, Stephen E. Dippe et al. · Diabetes · 1974 · 63 citations

Glomerular Disease, Renal Pathology, Glucose Tolerance +16